UA107655C2 - SELECTIVE BCL-2 ANTIAPOPTIC PROTEIN INHIBITORS FOR TREATMENT OF CANCER AND IMMUNE DISEASES - Google Patents
SELECTIVE BCL-2 ANTIAPOPTIC PROTEIN INHIBITORS FOR TREATMENT OF CANCER AND IMMUNE DISEASESInfo
- Publication number
- UA107655C2 UA107655C2 UAA201108414A UAA201108414A UA107655C2 UA 107655 C2 UA107655 C2 UA 107655C2 UA A201108414 A UAA201108414 A UA A201108414A UA A201108414 A UAA201108414 A UA A201108414A UA 107655 C2 UA107655 C2 UA 107655C2
- Authority
- UA
- Ukraine
- Prior art keywords
- antiapoptic
- cancer
- treatment
- immune diseases
- protein inhibitors
- Prior art date
Links
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 title abstract 3
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 208000026278 immune system disease Diseases 0.000 title 1
- 229940121649 protein inhibitor Drugs 0.000 title 1
- 239000012268 protein inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102100026596 Bcl-2-like protein 1 Human genes 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Описані сполуки, які інгібують активність антиапоптотичних білків Bcl-2 і Bcl-xL, композиції, що містять дані сполуки, і способи лікування захворювань, у ході яких експресується антиапоптичний білок Bcl-2.Compounds that inhibit the activity of the anti-apoptotic proteins Bcl-2 and Bcl-xL, compositions containing these compounds, and methods for treating diseases in which the anti-apoptotic protein Bcl-2 is expressed are described.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12027508P | 2008-12-05 | 2008-12-05 | |
| PCT/US2009/066790 WO2010065865A2 (en) | 2008-12-05 | 2009-12-04 | Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA107655C2 true UA107655C2 (en) | 2015-02-10 |
Family
ID=52989304
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201108414A UA107655C2 (en) | 2008-12-05 | 2009-04-12 | SELECTIVE BCL-2 ANTIAPOPTIC PROTEIN INHIBITORS FOR TREATMENT OF CANCER AND IMMUNE DISEASES |
| UAA201409941A UA110170C2 (en) | 2008-12-05 | 2009-12-04 | BCL-2 SELECTIVE AGENTS WHICH CAUSE APOPTOSIS FOR TREATMENT OF CANCER AND IMMUNE DISEASES |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201409941A UA110170C2 (en) | 2008-12-05 | 2009-12-04 | BCL-2 SELECTIVE AGENTS WHICH CAUSE APOPTOSIS FOR TREATMENT OF CANCER AND IMMUNE DISEASES |
Country Status (1)
| Country | Link |
|---|---|
| UA (2) | UA107655C2 (en) |
-
2009
- 2009-04-12 UA UAA201108414A patent/UA107655C2/en unknown
- 2009-12-04 UA UAA201409941A patent/UA110170C2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA110170C2 (en) | 2015-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA108193C2 (en) | APOPTOZINDUCE FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTO-IMMUNE DISEASES | |
| UA107706C2 (en) | APOPTOSIS-INDUCTIVE MEANS FOR TREATMENT OF CANCER AND IMMUNE AND AUTO-IMMUNE DISEASES | |
| CY1117655T1 (en) | FACTORS AFFECTING CANCER AND IMMUNE AND AUTOMATIC DISEASES TREATMENT | |
| PH12015500297A1 (en) | Adoptosis-inducing agents for the treatment of cancer and immune and automoimmune disease | |
| MY158932A (en) | Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | |
| PH12012501071A1 (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
| UA106640C2 (en) | Bcl-2-Selective Apoptosis Inducer for Cancer and Immune Diseases | |
| MX2011007681A (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases. | |
| SG10201406608YA (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
| NZ631701A (en) | Apoptosis-including agents for the treatment of cancer and immune and autoimmune diseases | |
| UA107655C2 (en) | SELECTIVE BCL-2 ANTIAPOPTIC PROTEIN INHIBITORS FOR TREATMENT OF CANCER AND IMMUNE DISEASES | |
| CY1116948T1 (en) | Causative Factors for the Therapeutic Treatment of Cancer and Immune and Autoimmune Diseases | |
| CY1116324T1 (en) | EFFECTIVENESS DERIVATIVES FACTORS FOR THE TREATMENT OF Cancer and Immune and Autoimmune Diseases |